Home Relationship between prolactin level and puberty in girls with early breast development
Article
Licensed
Unlicensed Requires Authentication

Relationship between prolactin level and puberty in girls with early breast development

  • Yun Jeong Lee ORCID logo and Seong Yong Lee ORCID logo EMAIL logo
Published/Copyright: August 9, 2022

Abstract

Objectives

Prolactin (PRL) stimulates the mammary glands development; however, it also inhibits gonadotropin-releasing hormone (GnRH) secretion. We evaluated the relationship between PRL levels and puberty in girls with precocious breast development.

Methods

This study included 244 girls with breast development < 8 years of age. Patients were categorized as central precocious puberty (CPP) [peak luteinizing hormone (LH) levels ≥ 5 IU/L after GnRH stimulation] versus non-CPP (NPP) group. High PRL was defined as serum PRL > 17.9 ng/mL.

Results

High PRL was more common in NPP than in CPP group (17.6 vs. 8.1%, p=0.025), although mean PRL levels did not differ. In NPP group, the high PRL group had lower peak LH/follicle-stimulating hormone (FSH) ratio, and later LH peak time after GnRH stimulation than normal PRL group (all p < 0.05). PRL levels of the subgroups according to the peak LH time (15, 30, 45, 60, and 90 min after GnRH stimulation) were different in NPP group, but not in CPP group. PRL levels tended to be higher as the peak LH time was delayed. High PRL was associated with decreased odds for CPP (OR=0.42, p=0.043).

Conclusions

Girls with NPP showed higher proportion of high PRL than CPP group. High PRL group showed more features of prepubertal response in NPP group, and associated with decreased odds for CPP, suggesting the possibility of PRL role on breast development while suppressing hypothalamic–pituitary–gonadal axis activation in NPP girls.


Corresponding author: Seong Yong Lee, MD, PhD, Department of Pediatrics, SMG-SNU Boramae Medical Center, 20 Boramae-Ro 5-Gil, Dongjak-Gu, Seoul 07061, Korea, Phone: +82 2 870 2363, Fax: +82 2 870 3363, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission. Study concept and design (SYL); data collection (SYL, YJL); analysis and interpretation of data (SYL, YJL); original draft (YJL): review and editing (SYL, YJL).

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent from the study participants and their guardians was waived by the Institutional Review Board (IRB) of SMG-SNU Boramae Medical Center.

  5. Ethical approval: The study adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) of SMG-SNU Boramae Medical Center (IRB No.10-2019-69).

References

1. Carel, JC, Léger, J. Precocious puberty. N Engl J Med 2008;358:2366–77. https://doi.org/10.1056/nejmcp0800459.Search in Google Scholar

2. Cheuiche, AV, da Silveira, LG, de Paula, LCP, Lucena, IRS, Silveiro, SP. Diagnosis and management of precocious sexual maturation: an updated review. Eur J Pediatr 2021;180:3073–87. https://doi.org/10.1007/s00431-021-04022-1.Search in Google Scholar

3. Grattan, DR. The hypothalamo-prolactin axis. J Endocrinol 2015;226:T101–22. https://doi.org/10.1530/joe-15-0213.Search in Google Scholar

4. Berryhill, GE, Trott, JF, Hovey, RC. Mammary gland development—it’s not just about estrogen. J Dairy Sci 2016;99:875–83. https://doi.org/10.3168/jds.2015-10105.Search in Google Scholar

5. Drummond, JB, Soares, BS, Pedrosa, W, Vieira, ELM, Teixeira, AL, Christ-Crain, M, et al.. Copeptin response to hypoglycemic stress is linked to prolactin activation in children. Pituitary 2020;23:681–90. https://doi.org/10.1007/s11102-020-01076-6.Search in Google Scholar

6. Grayson, RH, Halperin, JM, Sharma, V, Schwartz, ST, Koda, VH, Newcorn, JH. Changes in plasma prolactin and catecholamine metabolite levels following acute needle stick in children. Psychiatr Res 1997;69:27–32. https://doi.org/10.1016/s0165-1781(96)03048-x.Search in Google Scholar

7. Balijepalli, C, Druyts, E, Zoratti, MJ, Wu, P, Kanji, S, Rabheru, K, et al.. Change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: a network meta-analysis. Schizophr Res Treatment 2018;2018:1543034. https://doi.org/10.1155/2018/1543034.Search in Google Scholar PubMed PubMed Central

8. Druyts, E, Zoratti, MJ, Toor, K, Wu, P, Kanji, S, Rabheru, K, et al.. Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: a systematic review. BMC Pediatr 2016;16:181. https://doi.org/10.1186/s12887-016-0710-y.Search in Google Scholar PubMed PubMed Central

9. Melmed, S, Casanueva, FF, Hoffman, AR, Kleinberg, DL, Montori, VM, Schlechte, JA, et al.. Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:273–88. https://doi.org/10.1210/jc.2010-1692.Search in Google Scholar PubMed

10. Chen, AX, Burt, MG. Hyperprolactinaemia. Aust Prescr 2017;40:220–4. https://doi.org/10.18773/austprescr.2017.060.Search in Google Scholar PubMed PubMed Central

11. Eren, E, Yapıcı, Ş, Çakır, ED, Ceylan, LA, Sağlam, H, Tarım, Ö. Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases. J Clin Res Pediatr Endocrinol 2011;3:65–9.10.4274/jcrpe.v3i2.14Search in Google Scholar

12. Eren, E, Törel Ergür, A, İşgüven, ŞP, Çelebi Bitkin, E, Berberoğlu, M, Şıklar, Z, et al.. Clinical and laboratory characteristics of hyperprolactinemia in children and adolescents: national survey. J Clin Res Pediatr Endocrinol 2019;11:149–56. https://doi.org/10.4274/jcrpe.galenos.2018.2018.0206.Search in Google Scholar PubMed PubMed Central

13. Kim, JH, Yun, S, Hwang, SS, Shim, JO, Chae, HW, Lee, YJ, et al.. The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects. Korean J Pediatr 2018;61:135–49. https://doi.org/10.3345/kjp.2018.61.5.135.Search in Google Scholar PubMed PubMed Central

14. Abe, K, Matsuura, N, Nohara, Y, Fujita, H, Fujieda, K, Kato, T, et al.. Prolactin response to thyrotropin-releasing hormone in children with gynecomastia, premature thelarche and idiopathic precocious puberty. Tohoku J Exp Med 1984;142:283–8. https://doi.org/10.1620/tjem.142.283.Search in Google Scholar PubMed

15. Akinci, A, Cetin, D, Ilhan, N. Plasma Kisspeptin levels in girls with premature thelarche. J Clin Res Pediatr Endocrinol 2012;4:61–5. https://doi.org/10.4274/jcrpe.615.Search in Google Scholar PubMed PubMed Central

16. Page-Wilson, G, Smith, PC, Welt, CK. Prolactin suppresses GnRH but not TSH secretion. Horm Res 2006;65:31–8. https://doi.org/10.1159/000090377.Search in Google Scholar PubMed

17. Stawerska, R, Smyczyńska, J, Hilczer, M, Lewiński, A. Does elevated morning prolactin concentration in children always mean the diagnosis of hyperprolactinemia? Exp Clin Endocrinol Diabetes 2015;123:405–10. https://doi.org/10.1055/s-0035-1550018.Search in Google Scholar PubMed

18. García Barrado, MJ, Blanco, EJ, Carretero Hernández, M, Iglesias Osma, MC, Carretero, M, Herrero, JJ, et al.. Local transformations of androgens into estradiol by aromatase P450 is involved in the regulation of prolactin and the proliferation of pituitary prolactin-positive cells. PLoS One 2014;9:e101403. https://doi.org/10.1371/journal.pone.0101403.Search in Google Scholar PubMed PubMed Central

Received: 2022-02-20
Accepted: 2022-07-13
Published Online: 2022-08-09
Published in Print: 2022-09-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review Article
  3. Effects and dose-response relationships of exercise intervention on weight loss in overweight and obese children: a meta-regression and system review
  4. Original Articles
  5. Diabetic ketoacidosis in children with new-onset type 1 diabetes mellitus: demographics, risk factors and outcome: an 11 year review in Hong Kong
  6. Incidence tendency, etiological classification and outcome of congenital hypothyroidism in Guangzhou, China: an 11-year retrospective population-based study
  7. Metabolically healthy obesity in a paediatric obesity clinic
  8. Universal salt iodization potentially contributes to health equity: socio-economic status of children does not affect iodine status
  9. Association between clinical variations and copy number variations in cases with Turner syndrome
  10. The mediating function of obesity on endocrine-disrupting chemicals and insulin resistance in children
  11. Relationship between prolactin level and puberty in girls with early breast development
  12. Pattern of presentation of paediatric endocrine disorders in a Nigerian tertiary institution: an 11-year survey
  13. Case Reports
  14. Novel non-stop variant of the NR0B1 gene in two siblings with adrenal hypoplasia congenita
  15. Identification of two novel ACAT1 variant associated with beta-ketothiolase deficiency in a 9-month-old boy
  16. Craniosynostosis in a patient with Fanconi–Bickel syndrome: a case report
  17. Severe loss of adipose tissue in a Vietnamese lipodystrophy patient caused by LMNA p.G465D mutation: a first clinical characterization and two-year follow-up
  18. The response to growth hormone treatment in a child with short stature, growth hormone deficiency and autosomal dominant cutis laxa type 3 – case report
  19. Novel homozygous inactivating mutation in the luteinizing hormone receptor gene (LHCGR) associated with 46, XY DSD in a Moroccan family
Downloaded on 20.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2022-0093/html
Scroll to top button